# Bioxcel Therapeutics (BTAIQ): value investors who own it

1 value investor held Bioxcel Therapeutics in their Q3 2026 13F, led by Oaktree Capital Management.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Oaktree Capital Management | 0.0% | $1.9m | Added +472% | 5 |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/btaiq). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.